Somatostatin-dependent adenylyl cyclase activity in nonactivated and mitogen-activated human T cells: Evidence for uncoupling of sst3 receptor from adenylyl cyclase

Journal of Cellular Biochemistry

Volumn 72, Issue 2, 1999, Pages 221-231

  Giannetti, Nathalie ^a   Horvat, Branka ^b   Gautier, Nicole ^c   El Ghamrawy, Christelle ^d   Rabourdin Combe, Chantal ^b   Enjalbert, Alain ^e   Krantic, Slavica ^d  

^a UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^b UNIVERSITÉ DE LYON   (France)

^c UNIVERSITÉ LYON 1   (France)

^d INSERM   (France)

^e AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Adenylyl cyclase; Jurkat T cells; Mitogenic activation; Receptor subtypes; Somatostatin

Indexed keywords

ADENYLATE CYCLASE; CYCLIC AMP; FORSKOLIN; MESSENGER RNA; MITOGENIC AGENT; OCTREOTIDE; PHORBOL 13 ACETATE 12 MYRISTATE; PHYTOHEMAGGLUTININ; SOMATOSTATIN 14; SOMATOSTATIN 28; SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; LYMPHOCYTE MEMBRANE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

ADENYLATE CYCLASE; DOSE-RESPONSE RELATIONSHIP, DRUG; FORSKOLIN; HUMANS; JURKAT CELLS; MITOGENS; RECEPTORS, SOMATOSTATIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SOMATOSTATIN;

EID: 0033555306     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(19990201)72:2<221::AID-JCB6>3.0.CO;2-7     Document Type: Article

References (52)

1. Aguila MC, Dees WL, Haensly WE, McCann SM. 1991. Evidence that somatostatin is localized and synthesized in lymphoid organs. Proc Natl Acad Sci USA 88:11485-11489.
2. Aguila MC, Rodriguez AM, Aguila-Mansilla HN, Lee WT. 1996. Somatostatin antisense oligodeoxynucleotide-mediated stimulation of lymphocyte proliferation in culture. Endocrinology 137:1585-1590.
3. Alcover A, Ramarli D, Richardson NE, Chang H-C, Reinherez EL. 1987. Functional and molecular aspects of human T lymphocyte activation via T3-Ti and T11 pathway. Immunol Rev 95:5-36.
4. Aune TM, McGrath KM, Sarr T, Bombara MP, Kelley KA. 1993. Expression of 5HT1a receptors on activated human T cells. J Immunol 151:1175-1183.
5. Besedovsky HO, Del Rey A. 1996. Immune-neuro-endocrine interactions: Facts and hypothesis. Endocr Rev 17:64-102.
6. Bihoreau C, Heurtier A, Enjalbert A, Corvaia N, Bensussan A, Degos L, Kordon C. 1991. Activation of the CD3/T cell receptor (TcR) complex or of protein kinase C potentiate adenylyl cyclase stimulation in a tumoral T cell line: Involvement of two distinct intracellular pathways. Eur J Immunol 21:2877-2882.
7. Bost KL, Breeding SA, Pascual DW. 1992. Modulation of the mRNAs encoding substance P and its receptor in rat macrophages by LPS. Reg Immunol 4:105-112.
8. Cardoso A, El Ghamrawy C, Gautron JP, Horvat B, Gautier N, Enjalbert A, Krantic S. 1998. Somatostatin increases mitogen-induced IL-2 secretion and proliferation of human Jurkat T cells via sst3 receptor isotype. J Cell Biochem 68:62-73.
9. Carlson SL, Trauth K, Brooks WH, Roszman TL. 1994. Enhancement of beta-adrenergic-induced cAMP accumulation in activated T cells. J Cell Physiol. 161:39-48.
10. Enjalbert A, Sladeczek P, Guillon G, Bertrand P, Shu C, Epelbaum J, Garcia-Sainz JA, Jard S, Lombard S, Kordon C, Bockaert J. 1986. Angiotensin II and dopamine modulate both cAMP and inositolphosphate production in anterior pituitary cells. Involvement in prolactin secretion. J Biol Chem 261:4071-4079.
11. Epelbaum J. 1986. Somatostatin in the central nervous system: Physiology and pathological modification. Prog Neurobiol 27:63-100.
12. Farrar WL, Beckner SK. 1986. Biochemical convergance of prostaglandins and IL-2 on the adenylyl cyclase system. Transplant Proc [Suppl] 18:25-31.
13. Florio T, Schettini G. 1996. Multiple intracellular effectors modulate physiological functions of the cloned somatostatin receptors. J Mol Endocrinol 17:89-100.
14. Fratelli M, Gagliardini V, De Blasi A. 1989. Low affinity of beta-adrenergic receptors for agonists on intact cells is not due to receptor sequestration. Biochim Biophys Acta 1012:178-183.
15. Frohman MA, Dusch M, Martin GR. 1988. Rapid production of full-length cDNAs from rare transcripts: Amplification using a single gene-specific oligonucleotide primer. Proc Natl Acad Sci USA 85:8998-9002.
16. Gonsalkorale WM, Dascombe MJ, Hutchinson IV. 1993. Cyclic AMP inhibits macrophage suppressor function and enhances lymphocyte proliferation. Immunology 80:611-616.
17. Haraguchi S, Good RA, James-Yarish M, Cianciolo GJ, Day NK. 1995. Induction of intracellular cAMP by a synthetic retroviral envelope peptide: A possible mechanism of immunopathogenesis in retroviral infections. Proc Natl Acad Sci USA 92:5568-5571.
18. Hiruma K, Koike T, Nakamura H, Sumida T, Maeda T, Tomioka H, Yoshida S, Fujita T. 1990. Somatostatin receptors on human lymphocytes and leukaemia cells. Immunology 71:480-485.
19. Kammer GM. 1988. The adenylate cyclase-cAMP-protein kinase A pathway and regulation of the immune response. Immunol Today 9:222-229.
20. Kimata H, Yoshida A, Fujimoto M, Mikawa H. 1993. Effect of vasoactive intestinal peptide, somatostatin and substance P on spontaneous IgE and IgG4 production in atopic patients. J Immunol 150:4630-4640.
21. Krantic S, Robitaille Y, Quirion R. 1992. Deficits in the somatostatin SS1 receptor sub-type in frontal and temporal cortices in Alzheimer's disease. Brain Res 573:299-304.
22. Krantic S, Enjalbert A, Rabourdin-Combe C. 1997. Measles virus modulates human T-cell somatostatin receptors and their coupling to adenylyl cyclase. J Virol 71:7470-7477.
23. Kubota A, Yamada Y, Kagimoto S, Shimatsu A, Imamura M, Tsuda K, Imura H, Seino S, Seino Y. 1994. Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS 201-995 in treatment of human endocrine tumors. J Clin Invest 93:1321-1325.
24. Lalli E, Sassone-Corsi P, Cerdig R. 1996. Block of T lymphocyte differentiation by activation of the cAMP-dependent signal transduction pathway. EMBO J 15:528-537.
25. Lingk DS, Chan MA, Gelfand EW. 1990. Increased cyclic adenosine monophosphate levels block progression but not initiation of human T cell proliferation. J Immunol 145:449-455.
26. Lippert E, Baltensperger K, Jacques Y, Hermouet S. 1997. G-alpha16 protein expression is up- and down-regulated following T-cell activation: Disruption of this regulation impairs activation-induced cell responses. FEBS Lett 417:292-296.
27. Lowry OH, Rosebrough NJ, Farr AL, Randall R. 1951. Protein measurement with the folin phenol reagent. J Biol Chem 193:265-275.
28. Mary D, Aussel C, Ferrua B, Fehlmann M. 1987. Regulation of interleukin-2 synthesis by cAMP in human T cells. J Immunol 139:1179-1184.
29. McPherson GA. 1983. A practical computer-based approach to the analysis of radioligand binding experiments. Cornput Programs Biomed 17:107-114.
30. Miller GM, Alexander JM, Bikkal HA, Katznelson L, Zervas NT, Klibanski A. 1995. Somatostatin receptor subtype gene expression in pituitary adenomas. J Clin Endocrinol Metab 80:1386-1392.
31. Minakuchi R, Wacholtz MC, Davis LSD, Lipsky PE. 1990. Delineation of the mechanism of inhibition of human T-cell activation by PGE2. J Immunol 145:2616-2665.
32. Muscettola M, Grasso G. 1990. Somatostatin and vasoactive intestinal peptide reduce interferon gamma production by human peripheral blood mononuclear cells. Immunobiology 180:419-430.
33. Nio DA, Moylan RN, Roche JK. 1993. Modulation of T lymphocyte function by neuropeptides. J Immunol 150: 5281-5288.
34. Olianas MC, Onali P. 1996. Characterization of the G protein involved in the muscarinic stimulation of adenylyl cyclase of the rat olfactory bulb. Mol Pharmacol 49:22-29.
35. Onali P, Olianas MC, Luigi Gessa G. 1985. Characterization of dopamine receptors mediating inhibition of adenylyl cyclase activity in rat striatum. Mol Pharmacol 28:138-145.
36. Paliogianni F, Kincaid RL, Boumpas DT. 1993. Prostaglandin E2 and other cyclic AMP elevating agents inhibit interleukin-2 gene transcription by counteracting calcineurin-dependent pathways. J Exp Med 178:1813-1817.
37. Panetta R, Patel YC. 1994. Expression of mRNA for all five human somatostatin receptors (hSSTR1-5) in pituitary tumors. Life Sci 56:333-342.
38. Patel YC, Srikant CB. 1994. Subtype selectivity of peptide analogs for all five cloned human somatostatin receptors (hsstr 1-5). Endocrinology 135:2814-2817.
39. Raynor K, Reisine T. 1992. Somatostatin receptors. Crit Rev Neurobiol 16:273-289.
40. Reichlin S. 1987. Somatostatin. N Engl J Med 109:320-326.
41. Reisine T, Bell GI. 1995. Molecular biology of somatostatin receptors. Endocr Rev 16:427-442.
42. Rens-Domiano S, Law SF, Yamada Y, Seino S, Bell GI, Reisine T. 1992. Pharmacological properties of two cloned somatostatin receptors. Mol Pharmacol 42:28-34.
43. Rohrer L, Raulf F, Bruns C, Buettner R, Hofstaedter F, Schüle R. 1993. Cloning and characterization of the fourth human somatostatin receptor. Proc Natl Acad Sci USA 90:4196-4200.
44. Salomon Y, Londos C, Rodbell M. 1973. A highly sensitive adenylate cyclase assay. Anal Biochem 58:541-548.
45. Scicchitano R, Dazin P, Bienenstock J, Payan DG, Stanisz AM. 1988. The murine IgA-secreting plasmacytoma MOPC-315 expresses somatostatin receptors. J Immunol 141:937-941.
46. Seamon BK, Padgett W, Daly JW. 1981. Forskolin: Unique diterpene activator of adenylate cyclase in membranes and in intact cells. Proc Natl Acad Sci USA 78:3363-3367.
47. Seamon BK, Wetzel B. 1984. Interaction of forskolin with dually regulated adenylate cyclase. Adv Cyclic Nucleotide Protein Phosphorylation Res 17:91-99.
48. Sreedharan SP, Kodama KT, Peterson KE, Goetzl EJ. 1989. Distinct subsets of somatostatin receptors on cultured human lymphocytes. J Biol Chem 264:949-952.
49. Strom TB, Lane MA, George K. 1981. The parallel, time-dependent, bimodal change in lymphocyte cholinergic binding activity and cholinergic influence upon lymphocyte-mediated cytotoxicity after lymphocyte activation. J Immunol 127:705-710.
50. Tamir A, Isakov N. 1994. Cyclic AMP inhibits phosphatidylinositol-coupled and -uncoupled mitogenic signals in T lymphocytes. J Immunol 152:3391-3399.
51. van Tits LJH, Michel MC, Motulsky HJ, Maisel AS, Brodde OE. 1991. Cyclic AMP counteracts mitogen-induced inositol phosphate generation and increases in intracellular Ca2+ concentrations in human lymphocytes. Br J Pharmacol 103:1288-1294.
52. Yasuda K, Rens-Domiano S, Breder CD, Law SF, Saper CB, Reisine T, Bell GI. 1992. Cloning of a novel somatostatin receptor, SSTR3, coupled to adenylyl cyclase. J Biol Chem 267:20422-20428.